Literature DB >> 9692851

Determination of synapsin I and synaptophysin in body fluids by two-site enzyme-linked immunosorbent assays.

G Schlaf1, C Salje, A Wetter, K Stuertz, K Felgenhauer, M Mäder.   

Abstract

Two-site enzyme-linked immunosorbent assays (ELISA) have been established for the specific and sensitive determination of two membrane proteins of the small synaptic vesicles (SSV), namely: peripheral synapsin I and integral synaptophysin. The ELISA used highly specific capture monoclonal antibodies (mAB) and polyclonal antibodies (pAB) as detectors. For synapsin I, the mAB were newly generated, whereas for synaptophysin, the commercially available mAB SY38 was applied. In order to calibrate the ELISA and to raise pAB, both proteins were purified in the mg-range. Synapsin I was purified by conventional means from human and porcine brain and synaptophysin was purified by immunoaffinity chromatography from porcine brain. Using the ELISA, neither synapsin I nor synaptophysin could be determined in serum or cerebrospinal fluid (CSF) from healthy donors or patients suffering various neurological disorders or pheochromocytomas. For this reason, the degradation of both proteins in serum and CSF was investigated. With the exception of synaptophysin measured in serum, both proteins exhibited fast rates of degradation. Despite the negative results in human body fluids, the two ELISA are appropriate for the quantification of these membrane proteins in neuronal or neuroendocrine cell extracts or preparations of SSV.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9692851     DOI: 10.1016/s0022-1759(98)00027-1

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

1.  Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation.

Authors:  Holly Oakley; Sarah L Cole; Sreemathi Logan; Erika Maus; Pei Shao; Jeffery Craft; Angela Guillozet-Bongaarts; Masuo Ohno; John Disterhoft; Linda Van Eldik; Robert Berry; Robert Vassar
Journal:  J Neurosci       Date:  2006-10-04       Impact factor: 6.167

2.  Autoantibody synthesis in primary progressive multiple sclerosis patients treated with interferon beta-1b.

Authors:  Andreas Bitsch; Alexander Dressel; Kathrin Meier; Timon Bogumil; Florian Deisenhammer; Hayrettin Tumani; Bernd Kitze; Sigrid Poser; Frank Weber
Journal:  J Neurol       Date:  2004-12       Impact factor: 4.849

3.  Longitudinal GluCEST MRI Changes and Cerebral Blood Flow in 5xFAD Mice.

Authors:  Hironaka Igarashi; Satoshi Ueki; Hiroki Kitaura; Tae Kera; Ken Ohno; Masaki Ohkubo; Mika Terumitsu-Tsujita; Akiyoshi Kakita; Ingrid L Kwee
Journal:  Contrast Media Mol Imaging       Date:  2020-11-25       Impact factor: 3.161

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.